Computationally-Guided Optimization of a Docking Hit to Yield Catechol Diethers as Potent Anti-HIV Agents

被引:108
作者
Bollini, Mariela [2 ]
Domaoal, Robert A. [1 ]
Thakur, Vinay V. [2 ]
Gallardo-Macias, Ricardo [2 ]
Spasov, Krasimir A. [1 ]
Anderson, Karen S. [1 ]
Jorgensen, William L. [2 ]
机构
[1] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA
[2] Yale Univ, Dept Chem, New Haven, CT 06520 USA
基金
美国国家卫生研究院;
关键词
REVERSE-TRANSCRIPTASE INHIBITORS; NONNUCLEOSIDE INHIBITORS; BIOMOLECULAR SYSTEMS; ANTIVIRAL ACTIVITY; CRYSTAL-STRUCTURE; DISCOVERY; DRUG; DESIGN; DERIVATIVES; MUTATIONS;
D O I
10.1021/jm201134m
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A 5-mu M docking hit has been optimized to an extraordinarily potent (55 pM) non-nucleoside inhibitor of HIV reverse transcriptase. Use of free energy perturbation (PEP) calculations to predict relative free energies of binding aided the optimizations by identifying optimal substitution patterns for phenyl rings and a linker. The most potent resultant catechol diethers feature terminal uracil and cyanovinylphenyl groups. A halogen bond with Pro95 likely contributes to the extreme potency of compound 42. In addition, several examples are provided illustrating failures of attempted grafting of a substructure from a very active compound onto a seemingly related scaffold to improve its activity.
引用
收藏
页码:8582 / 8591
页数:10
相关论文
共 43 条
[1]   Nonnucleoside Reverse Transcriptase Inhibitor Resistance and the Role of the Second-Generation Agents [J].
Adams, Jessica ;
Patel, Nimish ;
Mankaryous, Nancy ;
Tadros, Mariam ;
Miller, Christopher D. .
ANNALS OF PHARMACOTHERAPY, 2010, 44 (01) :157-165
[2]   HEPT DERIVATIVES - 6-BENZYL-1-ETHOXYMETHYL-5-ISOPROPYLURACIL (MKC-442) [J].
BABA, M ;
TANAKA, H ;
MIYASAKA, T ;
YUASA, S ;
UBASAWA, M ;
WALKER, RT ;
DECLERCQ, E .
NUCLEOSIDES & NUCLEOTIDES, 1995, 14 (3-5) :575-583
[3]   3-Iodo-4-phenoxypyridinones (IOPY's), a new family of highly potent non-nucleoside inhibitors of HIV-1 reverse transcriptase [J].
Benjahad, A ;
Guillemont, J ;
Andries, K ;
Nguyen, CH ;
Grierson, DS .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (24) :4309-4312
[4]   Small molecule conformational preferences derived from crystal structure data. A medicinal chemistry focused analysis [J].
Brameld, Ken A. ;
Kuhn, Bernd ;
Reuter, Deborah C. ;
Stahl, Martin .
JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2008, 48 (01) :1-24
[5]   High-resolution structures of HIV-1 reverse transcriptase/TMC278 complexes: Strategic flexibility explains potency against resistance mutations [J].
Das, Kalyan ;
Bauman, Joseph D. ;
Clark, Arthur D., Jr. ;
Frenkel, Yulia V. ;
Lewi, Paul J. ;
Shatkin, Aaron J. ;
Hughes, Stephen H. ;
Arnold, Eddy .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (05) :1466-1471
[6]   The design of drugs for HIV and HCV [J].
De Clercq, Erik .
NATURE REVIEWS DRUG DISCOVERY, 2007, 6 (12) :1001-1018
[7]   HIV drug development: the next 25 years [J].
Flexner, Charles .
NATURE REVIEWS DRUG DISCOVERY, 2007, 6 (12) :959-966
[8]   Synthesis of 1-[cis-3-(hydroxymethyl)cyclobutyl]-uracil, -thymine and -cytosine [J].
Frieden, M ;
Giraud, M ;
Reese, CB ;
Song, QL .
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1, 1998, (17) :2827-2832
[9]   Systematic Investigation of Halogen Bonding in Protein-Ligand Interactions [J].
Hardegger, Leo A. ;
Kuhn, Bernd ;
Spinnler, Beat ;
Anselm, Lilli ;
Ecabert, Robert ;
Stihle, Martine ;
Gsell, Bernard ;
Thoma, Ralf ;
Diez, Joachim ;
Benz, Joerg ;
Plancher, Jean-Marc ;
Hartmann, Guido ;
Banner, David W. ;
Haap, Wolfgang ;
Diederich, Francois .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2011, 50 (01) :314-318
[10]   Crystal structures for HIV-1 reverse transcriptase in complexes with three pyridinone derivatives: A new class of non-nucleoside inhibitors effective against a broad range of drug-resistant strains [J].
Himmel, DM ;
Das, K ;
Clark, AD ;
Hughes, SH ;
Benjahad, A ;
Oumouch, S ;
Guillemont, J ;
Coupa, S ;
Poncelet, A ;
Csoka, I ;
Meyer, C ;
Andries, K ;
Nguyen, CH ;
Grierson, DS ;
Arnold, E .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (24) :7582-7591